FULC

3.6850.67%
BE

Bradley E. Bernstein

Founder

Dr. Bradley E. Bernstein, also known as Brad, M.D., Ph.D. is Founder of HiFiBiO SAS and was its Member of Scientific Advisory Board. He also serves as Member of Scientific Advisory Board at The Sontag Foundation since 2020. He is Co-Founder of Arsenal Biosciences, Inc. He serves as Chair of Department of Cancer Biology at Dana-Farber Cancer Institute, Inc. since 2021. He serves as a Member of Scientific Advisory Board at Syros Pharmaceutical, Inc. Dr. Bernstein serves as a Member of Scientific Advisory Board of HiFiBiO SAS since October 2019. He is the Founder of Fulcrum Therapeutics, Inc. He serves on numerous scientific advisory boards including the UCLA Jonsson Comprehensive Cancer Center and the MD Anderson Cancer Center's Moon Shots Program. Dr. Bernstein is Member of Massachusetts General Hospital, Harvard Stem Cell Institute, Harvard Medical School, Howard Hughes Medical Institute and Broad Institute. He is Director of the Gene Regulation Observatory at the Broad Institute. Dr. Bernstein is also on the Board of Reviewing Editors, Science and serves on the Editorial Boards of Genome Research, Molecular and Cellular Biology, Cell Research, Epigenetics & Chromatin and Human Molecular Genetics. Dr. Bernstein is a Professor of Pathology at Massachusetts General Hospital and Harvard Medical School and Director of the Epigenomics Program at the Broad Institute. Dr. Bernstein received his B. S. from Yale University in 1992 and his M. D. and Ph. D. from University of Washington School of Medicine.

Positions